MC2 Therapeutics
Major Drugs - N/A, ENG, UK
MC2 Therapeutics Employees
Henriette Kristensen
Commercial Director Europe, consumer healthcare products
MC2 Therapeutics Senior Management
MC2 Therapeutics Details
MC2 Therapeutics is a commercial stage pharmaceutical company committed to optimize the treatment experience and address unmet needs for patients with topical autoimmune and chronic inflammatory conditions. Using our novel PAD™ Technology as a cornerstone of our topical formulations we develop innovative best-in-class or first-in-class topical therapies tailored for fast and safe relief of symptoms in formulations that patients prefer to use in daily routines. MC2 is headquartered in Denmark. This page is not intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about MC2 Therapeutics and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Please keep in mind that MC2 Therapeutics work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of MC2 Therapeutics.
MC2 Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Apache
Domain Name Services
Cloudflare DNS
CMS
WP Engine
Other
Microsoft Office 365